Catheter Thrombolysis with Streptokinase, Urokinase, and Recombinant Tissue Plasminogen Activator for Peripheral Arterial Occlusion

  • D. D. Do
  • F. Mahler
  • J. Triller


Percutaneous transluminal angioplasty (PTA) of peripheral arteries has so far been limited to relatively short lesions which should not be too solidified for penetration by the instrument or too fresh because of the danger of embolization into the runoff vessels during manipulation [4, 7]. The introduction of intraarterial local catheter thrombolysis (CTL) has made possible the catheter treatment of acute and subacute thrombotic occlusions including extensive lesions [3, 8–11]. CTL with low-dose streptokinase or urokinase is a procedure with a low risk and with satisfactory long-term patency in patients with femoropopliteal occlusions. A new tissue-type plasminogen activator produced by recombinant technology (rt-PA) that possesses advantages over conventional thrombolytic agents seems to hold promise for more potent and selective lysis of peripheral arterial thrombotic occlusions [1]. In this paper we present technique and dosage of the application of these three thrombolytic drugs, and the results obtained with these modalities in 142 patients from 1982 through 1987.


Thrombotic Occlusion Recombinant Tissue Plasminogen Activator Ankle Pressure Recombinant Tissue Type Plasminogen Activator Peripheral Arterial Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Collen D, Lijnen HR (1986) Tissue-type plasminogen activator. Mechanism of action and thrombolytic properties. Haemostasis 16 (suppl 3): 25–32PubMedGoogle Scholar
  2. 2.
    Collen D, Topol EJ, Tiefenbrunn AJ (1984) Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation 70: 1012–1017PubMedCrossRefGoogle Scholar
  3. 3.
    Do DD, Mahler F, Triller J, Nachbur B (1987) Combination of short- and long-time thrombolysis for peripheral arterial occlusion. Eur J Radiol 7: 235–238Google Scholar
  4. 4.
    Gallino A, Mahler F, Probst P, Nachbur B (1984) Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 70: 619–623PubMedCrossRefGoogle Scholar
  5. 5.
    Goldhaber SZ, Vaughan DA, Markis JE (1986) Acute pulmonary embolism treated with tissue type plasminogen activator. Lancet ii: 886–889CrossRefGoogle Scholar
  6. 6.
    Graor RA, Risius B (1987) Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft thrombosis. In: Sobel BE, Collen D, Grossbard EB (eds) Tissue plasminogen activator in thrombolytic therapy. Dekker, Basel, pp 171–204Google Scholar
  7. 7.
    Grüntzig A (1977) Die perkutane transluminale Rekanalisation chronischer Arterienver-schlüsse mit einer neuen Dilatationstechnik. Witzstrock, Baden-BadenGoogle Scholar
  8. 8.
    Hess H, Ingrisch H, Mietaschk A, Rath H (1982) Local low-dose thrombolytic therapy of peripheral artery occlusions. N Engl J Med 307: 1627–1630PubMedCrossRefGoogle Scholar
  9. 9.
    Hess M, Mietaschk A, Brückl R (1987) Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy. Radiology 163: 753–758PubMedGoogle Scholar
  10. 10.
    Katzen BT, Edward KC, Albert AS, van Breda A (1984) Low-dose direct fibrinolysis in peripheral vascular disease. J Vase Surg 1: 718–722Google Scholar
  11. 11.
    Sicard GA, Schier JJ, Totty WG, Gilula LA, Walker WB, Etheredge EE, Anderson CB (1985) Thrombolytic therapy for acute arterial occlusion. J Vase Surg 2: 65–78Google Scholar
  12. 12.
    TIMI-Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trail. Phase I findings. N Engl J Med 312: 932–936Google Scholar
  13. 13.
    Verstraete M, Bleifeld W, Brower RW (1985) Double-blind randomized trial of intravenous tissue-type plasminogen activator in acute myocardial infarction. Lancet ii: 965–969CrossRefGoogle Scholar
  14. 14.
    Verstraete M, Hess H, Mahler F, Mietaschk A, Roth FJ, Schneider E, Baert AL, Verhaeghe R (1988) Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue type plasminogen activator — report of a pilot trial. Eur J Vase Surg 2: 155–159CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. D. Do
  • F. Mahler
  • J. Triller

There are no affiliations available

Personalised recommendations